Pediatric Study for Appropriate Dose of Ritonavir Boosted Lopinavir in Thai HIV-infected Children (PEARL)
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
To compare the safety and efficacy of low-dose versus standard dose lopinavir/ritonavir
containing HAART regimen in virological suppress, HIV RNA viral load < 50 copies/ml at 48
week
Phase:
Phase 3
Details
Lead Sponsor:
The HIV Netherlands Australia Thailand Research Collaboration
Collaborators:
Bamrasnaradura Infectious Diseases Institute Buddhachinaraj Hospital Chulalongkorn University Nakornping Hospital Phrachomklao Hospital Prapokklao Hospital Queen Sirikit National Institute of Child Health Sappasitthiprasong Hospital Srinagarind Hospital, Khon Kaen University Surin Hospital Udonthani Hospital